BEST PODIUM AND POSTER PRESENTATIONS AWARDED AT ISPOR 19TH ANNUAL EUROPEAN CONGRESS

Published Nov 22, 2016
Princeton, NJ—November 22, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recognized the Best Podium Presentation and Best Poster Presentation Awardees at its 19th Annual European Congress in Vienna, Austria. The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, Asia-Pacific and Latin America Conferences.   BEST PODIUM PRESENTATION AWARDS  Best General Podium Presentation Awards
  • Helen Johnson HT1-ALIGNED AND FLEXIBLE? A COMPARATIVE REVIEW OF SMC AND NICE DECISION-MAKING
  • Lucia Perez AD3-MEDICATION ADHERENCE AND PERSISTANCE IN TYPE 2 DIABETES MELLITUS (T2DM): PATIENTS PERSPECTIVE IN THS SPANISH HEALTH CARE SYSTEM
  • Stephane Bouee DB1-MORTALITY EXCESS DUE TO CLOSTRIDIUM DIFFICILE INFECTION, A NATIONAL DATABASE ANALYSIS
Best Student Podium Presentation Awards
  • Xiaohan Hu ND1-BURDEN AND WORK PRODUCTIVITY LOSS IMPAIRMENT FROM PROVIDING CARE TO ALZHEIMER'S DISEASE PATIENTS
  • Ellen M. Janssen PP1-NINE TESTS FOR ASSESING VALIDITY OF A DISCRETE-CHOICE EXPERIMENT
  • Amir Ansaripour DB4-USE OF DATA-MINING TO PERFORM A REAL WORLD COST ANALYSIS OF HER2-POSITIVE BREAST CANCER IN IRAN 
Best New Investigator Podium Research Presentations
  • Erica Visintin HT6-CRITERIA DRIVING VALUES ASSESSMENTS IN MULTIPLE SCLEROSIS MEDICINES
  • William Vincent Padula EE2-IS IT REALLY COST-EFFECTIVE TO RISK-ASSESS ALL HOSPITALIZED PATIENTS FOR PRESSURE ULCERS EVERY NURSING-SHIFT?
  • Vera Vennedey PP2-PATIENTS' PREFERENCES FOR CHARACTERISTICS OF PERIODONTAL DISEASE AND ITS' TREATMENT: A DISCRETE CHOICE EXPERIMENT
  BEST POSTER RESEARCH PRESENTATION AWARDS  Best General Poster Research Presentations
  • Nicolas Despiegel PRM143-QUALITY OF LIFE OF PATIENTS TREATED FOR MULTIPLE MYELOMA (MM) IN FRANCE IN A REAL-WORLD SETTING
  • Nadia Sutton PGI8-RATE AND HEALTHCARE UTILIZATION (LOS AND COSTS) OF ADHESION RELATED COMPLICATIONS AFTER COLON RESECTION PROCEDURES
  • F Randon PSY69-COST-EFFECTIVENESS ANALYSIS OF IBRUTINIB FOR WALDENSTRÖM MACROGLOBULINEMIA IN ITALY
Best Student Poster Research Presentations
  • Frédérique Cornélie Wilhelmina van Krugten PMH48-FEASIBILITY, RELIABILITY AND VALIDITY OF THE DECISION TOOL UNIPOLAR DEPRESSION (DTUD) IN IDENTIFYING PATIENTS WITH MAJOR DEPRESSIVE DISORDER IN NEED OF HIGHLY SPECIALIZED CARE
  • Katarzyna Orlewska PHP96-COST OF LOST PRODUCTIVITY DUE TO PREMATURE, SUICIDE-RELATED MORTALITY IN POLAND
  • Saara Huoponen PMS43-A COST-EFFECTIVENESS ANALYSIS OF ABATACEPT, TOCILIZUMAB, AND TNF-INHIBITOR COMPARED WITH RITUXIMAB AS A SECOND-LINE THERAPY FOR TREATMENT OF RHEUMATOID ARTHRITIS
Best New Investigator Poster Research Presentations
  • Lulu K. Lee PDB92-CHARACTERISTICS OF PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON BASAL INSULIN REGIMENS: RETROSPECTIVE ANALYSIS OF ELECTRONIC HEALTH RECORD DATA
  • Inês Ribeiro PCN157-ECONOMIC EVALUATION OF PERTUZUMAB IN COMBINATION WITH TRASTUZUMAB AND DOCETAXEL IN THE NEOADJUVANT TREATMENT OF WOMEN WITH HER2-POSITIVE, LOCALLY ADVANCED, INFLAMMATORY OR EARLY BREAST CANCER IN PORTUGAL
  • Los PHS141-THE INCREASING IMPORTANCE OF A CONTINENCE NURSE SPECIALIST TO IMPROVE OUTCOMES AND SAVE COSTS OF URINARY INCONTINENCE CARE: AN ANALYSIS OF FUTURE POLICY SCENARIOS
  A complete list of the award winners can be found here. Additional information on the ISPOR 19th Annual European Congress can be found here. Released presentations from the congress can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORVienna.

###

Related Stories

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.

ISPOR Europe 2025 Plenaries and Speakers Announced

Oct 13, 2025

ISPOR announced details for its ISPOR Europe 2025. The conference is the leading global conference in Europe for health economics and outcomes research (HEOR) and is scheduled for 9-12 November in Glasglow, Scotland, UK with the theme, “Powering Value and Access Through Patient-Centered Collaboration.”

ISPOR Launches New Content on Whole Health

Sep 23, 2025

ISPOR announced that it has launched new website content on whole health, a topic of increasing importance as health systems across the globe grapple with providing the best possible healthcare to patients within constrained budgets.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×